Crossref
journal-article
Elsevier BV
Neurobiology of Disease (78)
References
59
Referenced
100
10.1016/0092-8674(93)90585-E
/ Cell / A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. (1993)10.1016/0166-2236(95)93943-R
/ Trends Neurosci. / Genetics and molecular biology of Huntington's disease by Albin (1995)10.1038/39885
/ Nature / Anterograde transport of brain-derived neurotrophic factor and its role in the brain by Altar (1997)10.1016/S0169-328X(97)00180-0
/ Brain Res. Mol. Brain Res. / Localization of putative calcium-responsive regions in the rat BDNF gene by Bishop (1997)10.1097/00001756-199712010-00033
/ NeuroReport / Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats by Block (1997)10.1097/00001756-200105250-00041
/ NeuroReport / Rolipram reduces excitotoxic neuronal damage by Block (2001)10.1016/j.brainres.2003.10.058
/ Brain Res. / Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion by Block (2004)10.1016/j.neulet.2007.03.033
/ Neurosci. Lett. / Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation by Chen (2007)10.1002/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R
/ J. Comp. Neurol. / Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect by Cherry (1999)10.1046/j.1471-4159.1994.63020509.x
/ J. Neurochem. / Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents by Condorelli (1994)10.1523/JNEUROSCI.17-07-02295.1997
/ J. Neurosci. / Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport by Conner (1997){'key': '10.1016/j.nbd.2008.02.010_bb0060', 'first-page': '431', 'article-title': 'Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders', 'volume': '40', 'author': 'Cramer', 'year': '1984', 'journal-title': 'Adv. Neurol.'}
/ Adv. Neurol. / Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders by Cramer (1984)10.1016/S0092-8674(00)80513-9
/ Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by Davies (1997)10.1016/j.nbd.2006.09.006
/ Neurobiol. Dis. / Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity by DeMarch (2007)10.1126/science.277.5334.1990
/ Science / Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain by DiFiglia (1997)10.1016/S0893-133X(99)00084-6
/ Neuropsychopharmacology / Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus by Fujimaki (2000)10.1523/JNEUROSCI.19-04-01189.1999
/ J. Neurosci. / Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease by Fusco (1999)10.1046/j.1460-9568.2003.02844.x
/ Eur. J. Neurosci. / Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain by Fusco (2003)10.1111/j.1460-9568.2005.04545.x
/ Eur. J. Neurosci. / Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease by Giampa (2006)10.1093/hmg/ddg046
/ Hum. Mol. Genet. / Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice by Gines (2003)10.1172/JCI22831
/ J. Clin. Invest. / Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment by Gong (2004)10.1016/S0006-8993(02)04275-0
/ Brain Res. / Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression by Hansson (2003)10.1016/S0143-4160(98)90111-7
/ Cell Calcium / Mechanisms controlling gene expression by nuclear calcium signals by Hardingham (1998)10.1016/j.neuroscience.2003.11.009
/ Neuroscience / Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms by Hebb (2004)10.1602/neurorx.1.3.298
/ NeuroRx / Translating therapies for Huntington's disease from genetic animal models to clinical trials by Hersch (2004)10.1002/ana.10094
/ Ann. Neurol. / Environmental enrichment slows disease progression in R6/2 Huntington's disease mice by Hockly (2002)10.1007/s00702-002-0797-1
/ J. Neural. Transm. / Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain by Hosoi (2003)10.1016/j.ejphar.2004.07.084
/ Eur. J. Pharmacol. / Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats by Itoh (2004)10.1038/sj.bjp.0705927
/ Br. J. Pharmacol. / Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism by Jacob (2004)10.1093/hmg/ddg002
/ Hum. Mol. Genet. / Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein by Jiang (2003)10.1016/S0165-0270(99)00142-9
/ J. Neurosci. Methods / A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections by Jiao (1999)10.1073/pnas.96.20.11404
/ Proc. Natl. Acad. Sci. U. S. A. / Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells by Kazantsev (1999)10.1097/00001756-199912160-00031
/ Neuroreport / Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice by Kosinski (1999)10.1002/ana.20259
/ Ann. Neurol. / cAMP response element-binding protein activation in ligation preconditioning in neonatal brain by Lee (2004)10.1074/jbc.C500140200
/ J. Biol. Chem. / Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival by Lee (2005)10.1016/S0896-6273(02)00828-0
/ Neuron / Function and regulation of CREB family transcription factors in the nervous system by Lonze (2002)10.1093/hmg/9.9.1259
/ Hum. Mol. Genet. / Decreased expression of striatal signaling genes in a mouse model of Huntington's disease by Luthi-Carter (2000)10.1016/j.neulet.2006.10.039
/ Neurosci. Lett. / Metformin therapy in a transgenic mouse model of Huntington's disease by Ma (2007)10.1042/bj3470571
/ Biochem. J. / Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells by MacKenzie (2000)10.1016/S0092-8674(00)81369-0
/ Cell / Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice by Mangiarini (1996)10.1038/ng882
/ Nat. Genet. / Disruption of CREB function in brain leads to neurodegeneration by Mantamadiotis (2002)10.1002/cne.10295
/ J. Comp. Neurol. / Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice by Meade (2002)10.1038/sj.npp.1300813
/ Neuropsychopharmacology / Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear by Monti (2006)10.1038/sj.bjp.0704629
/ Br. J. Pharmacol. / Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats by Nagakura (2002)10.1523/JNEUROSCI.16-07-02365.1996
/ J. Neurosci. / Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus by Nibuya (1996)10.1126/science.1056784
/ Science / Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity by Nucifora (2001)10.1016/j.bbadis.2005.11.002
/ Biochim. Biophys. / Combination therapy using mynocicline and coenzyme Q in R6/2 muse model of Huntington's disease by Stack (2006)10.1073/pnas.100110097
/ Proc. Natl. Acad. Sci. U. S. A. / The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription by Steffan (2000)10.1038/35099568
/ Nature / Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila by Steffan (2001)10.1016/S0168-9525(03)00074-X
/ Trends Genet. / Transcriptional abnormalities in Huntington disease by Sugars (2003)10.1074/jbc.M310226200
/ J. Biol. Chem. / Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis by Sugars (2004)10.1016/S0169-328X(96)00144-1
/ Brain Res. Mol. Brain Res. / The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic–ischemic brain damage and repair by Walton (1996)10.1016/S0166-2236(99)01500-3
/ Trends Neurosci. / Is CREB a key to neuronal survival? by Walton (2000)10.1080/01688638708405354
/ J. Clin. Exp. Neuropsychol. / Memory failure in Huntington's disease by Wilson (1987)10.1093/hmg/10.17.1829
/ Hum. Mol. Genet. / Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease by Wyttenbach (2001)10.1002/j.1460-2075.1990.tb07564.x
/ EMBO J. / Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors by Zafra (1990)10.1523/JNEUROSCI.12-12-04793.1992
/ J. Neurosci. / Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes by Zafra (1992)10.1126/science.1059581
/ Science / Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease by Zuccato (2001)10.1016/j.pneurobio.2007.01.003
/ Prog. Neurobiol. / Role of brain-derived neurotrophic factor in Huntington's disease by Zuccato (2007)
Dates
Type | When |
---|---|
Created | 17 years, 5 months ago (March 10, 2008, 5:01 p.m.) |
Deposited | 4 years, 8 months ago (Dec. 18, 2020, 7:29 p.m.) |
Indexed | 4 months, 3 weeks ago (April 2, 2025, 12:25 p.m.) |
Issued | 17 years, 2 months ago (June 1, 2008) |
Published | 17 years, 2 months ago (June 1, 2008) |
Published Print | 17 years, 2 months ago (June 1, 2008) |
@article{DeMarch_2008, title={Beneficial effects of rolipram in the R6/2 mouse model of Huntington’s disease}, volume={30}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2008.02.010}, DOI={10.1016/j.nbd.2008.02.010}, number={3}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={DeMarch, Zena and Giampà, Carmela and Patassini, Stefano and Bernardi, Giorgio and Fusco, Francesca Romana}, year={2008}, month=jun, pages={375–387} }